跳至主要内容
临床试验/NCT03509025
NCT03509025已完成2 期

Open, Multicenter Follow-up Trial About Active Group of Phase IIb Clinical Trial of JOINTSTEM in Patients With Degenerative Arthritis

R-Bio2 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2017年2月8日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
11
试验地点
2
主要终点
Adverse Events

研究概览

简要总结

This study is a long term follow-up study to investigate the safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with Knee Osteoarthritis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must consent in writing to participate in the study by signing and dating an informed consent document
  • Patients who transplanted Jointstem on phase 2b clinical trial

排除标准

  • Preparing for Pregnancy or Pregnant women or lactating mothers.
  • Patients who the principal investigator considers inappropriate for the clinical tria

研究组 & 干预措施

Long Term Follow-up after Jointstem Transplantation

Experimental

干预措施: Jointstem (Drug)

结局指标

主要结局

Adverse Events

时间窗: 60 months

Incidence of adverse events from baseline to 60 months

次要结局

  • WOMAC 3 subscale score(Baseline and 12 months)
  • X-ray(Baseline and 12 months)
  • WOMAC score(Baseline and 12 months)

研究者

发起方
R-Bio
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验